Trifluoroacetic Acid: A Narrative Review
Toxics · 29.10.2026 · 14 (11) · 964
DOI: 10.3390/toxics14110964 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxics, online erschienen am 29.10.2026. Verfasst von Alexandra Kristian und 3 weiteren Autor:innen. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Among the well-known category of perfluorinated substances (PFAS), trifluoroacetic acid (TFA) has received less scientific attention for a long time, mainly due to chemical properties that deviate from classical persistent pollutants. In recent years, mounting evidence has emerged that demonstrates environmental persistence and widespread as well as growing distribution of TFA in combination with specific effects relevant for human health. The new scientific view on TFA represents a challenge to regulatory authorities, as it requires new considerations that cannot be directly derived from classical PFAS. In this narrative review we aim to provide a comprehensive overview of established and currently evolving aspects of TFA as a pollutant that just entered the main stage of environmental science and toxicology. Overall, this review highlights the relevance of TFA as a persistent environmental pollutant despite its physicochemical differences from classical PFAS and calls for appropriate recognition by regulatory authorities and in public awareness.
Zitieren
APA
Kristian, A., Poteser, M., Hutter, H., & Moshammer, H. (2026). Trifluoroacetic Acid: A Narrative Review. Toxics, 14(11), 964. https://doi.org/10.3390/toxics14110964
Vancouver
Kristian A, Poteser M, Hutter H, Moshammer H. Trifluoroacetic Acid: A Narrative Review. Toxics. 2026;14(11):964. doi:10.3390/toxics14110964
BibTeX
@article{Kristian2026,
author = {Kristian, Alexandra and Poteser, Michael and Hutter, Hans-Peter and Moshammer, Hanns},
title = {Trifluoroacetic Acid: A Narrative Review},
journal = {Toxics},
year = {2026},
volume = {14},
number = {11},
pages = {964},
doi = {10.3390/toxics14110964}
}
EUVIMED